According to the International Diabetes Federation, an estimated 425 million people worldwide are living with diabetes. The disease, which affects everyone differently, is complex and costly to manage. Yet, most of the burden for care lands on the patients themselves, with many not in glycemic control. How could Medtronic, a global healthcare solutions company, help people living with diabetes in their daily management and help them keep their glucose levels in the target range?

Insight

Diabetes is personal

We all live differently — different diets, exercise habits, sleep patterns, routines. What’s more, we each react in our own way to certain events and work demands and respond differently to the food we eat. For diabetes management to be more effective, it has to be more individualized.

Idea

Design a personal diabetes assistant

Medtronic worked with IBM iX™ and IBM Watson Health™ teams to develop the Sugar.IQ personal diabetes assistant, an intelligent app powered by IBM Watson® cognitive computing technology. Sugar.IQ is designed to make daily diabetes management smarter and more personalized than ever before. The app continually analyzes how an individual’s glucose levels respond to food, insulin intake, daily routines and other factors. By uncovering patterns and real-time, eye-opening insights, people can understand their glucose in context to their lifestyle choices.

Using the IBM Design Thinking framework and principles, the iX team partnered with Medtronic to develop the app’s user interface and user experience, and assisted in delivering an end-to-end solution. Features include a smart food logging system, motivational insights, a glycemic assistant, a data tracker and glycemic insights, Glycemic Assist event tracking, and personalized diabetes insights. The team also strategized ways to incorporate cognitive capabilities into the app and researched a way to differentiate this app from other diabetes apps in the market today.

The Sugar.IQ personal diabetes assistant is exclusively available to Guardian Connect continuous glucose monitoring (CGM) customers on insulin injections and is available for iOS-based mobile devices in the US.

Goal

Improved quality of life with more time living in a healthy glucose range

The Sugar.IQ app is already helping to enhance lives, providing people with diabetes new cognitive insights that weren’t available until now.

In June 2018, Medtronic presented real-world data at the 78th Annual American Diabetes Association (ADA) Scientific Sessions showing that patients with Medtronic 530G pumps who used the Sugar.IQ app for a period of four months spent an average of 36 minutes more per day in healthy glucose range than they did before using the app. This included an average of 30 minutes less time per day in hyperglycemia (>180 mg/dL) and six minutes less time per day in hypoglycemia (<70 mg/dL).i If these averages are applied over a full year, they would represent an average of more than nine additional days per year in a healthy glucose range. Researchers also noted that the number of episodes with low glucose levels decreased by 0.95 per month and high episodes decreased on average by 1.22 a month.ii

For more about the app, watch the video Introducing the Sugar.IQ diabetes assistant. Read more about IBM and Medtronic in this Medtronic case study.

For people with diabetes that used Sugar.IQ Personal Diabetes Assistant App achieved on average:

9 days

in a year spent in a healthy glucose range

 
 

6 minutes

less time in hypoglycemia (<70 mg/dL)

30 minutes

less time in hyperglycemia (>180 mg/dL)

 
 

36 minutes

more per day spent in their healthy glucose range

 

We wouldn’t have been able to make this project a reality without the partnership, technology and expertise of IBM. The IBM team collaboration helped us deliver a truly unique patient experience, leveraging their experts in design, cognitive computing and mobile app development — all within a quality control management system.

—Amit Singh, IT Director of Digital Platforms, Medtronic

IMPORTANT SAFETY INFORMATION

Sugar.IQ Personal Diabetes Assistant App

The Food and My Food Diary screens are intended for logging meals and counting carbs to promote a healthy diet. The My Data and Glycemic Assist screens and the insights on the Home screen are intended for use as data reporting tools to help you identify historical trends and the effects of daily activities on glucose levels. The SG History screen, including the current sensor glucose reading, is intended for use as an additional display of CGM data for passive monitoring.

The Sugar.IQ app is not intended to provide medical advice and should not be relied upon for such purpose. Do not make any changes to treatment without talking to a healthcare professional (HCP) first. The app is not intended to replace the real-time display of the CGM data on the Guardian Connect app. The app is not intended to control any functions of the connecting device. The app is not intended for calculating insulin or other drug doses. The app will not modify data or control functions of the Guardian Connect system. All therapy decisions should be made by the app user based on blood glucose (BG) measurements obtained from a BG meter.

Meet some
of our clients:

ExxonMobil

Retail
Irving, Texas USA

Read the case study

FOX Sports

Sports, Media & Entertainment
Los Angeles, California USA

Read the case study

Amica

Insurance
Lincoln, Rhode Island USA

Read the case study

Turkcell

Telecommunications
Istanbul, Turkey

Read the case study

 
 

 

Sorry, we couldn't find results that match your criteria

insurance
strategy,design,mobile,platforms

Amica

Insurance
Lincoln, Rhode Island USA

transportation
mobile,design

Asia Miles

Transportation
Hong Kong, China

retail
mobile,design

DSW

Retail
Columbus, Ohio USA

telecommunications
strategy,mobile,design

Du

Telecommunications
Dubai, United Arab Emirates

insurance,health
strategy,mobile,design

IBM Service Hub

Technology
Hamburg, Germany

transportation
mobile,design

Japan Airlines

Transportation
Tokyo, Japan

health
mobile,design,strategy

Medtronic

Health
Minneapolis, Minnesota USA

retail
platforms,mobile,design

Migros

Retail
Zurich, Switzerland

retail,telecommunications
salesforce,mobile,design

T-Mobile

Retail | Telecommunications
Seattle, Washington USA

telecommunications
design,strategy,mobile

Turkcell

Telecommunications
Istanbul, Turkey

Ready to see what we can
do for your business?

Say hello!

Financing iX

Explore the
latest insights:

i Usage of Sugar.IQ app was analyzed based on data from 256 randomly offered, real-world MiniMed 530G users from April to August 2017.
ii Users remained on 530G threshold suspend during the observed period.